US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 20:34:03 Source：Stellar Stories news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Ben Whishaw lights up the Croisette as he joins his co
- Next：Company wins court ruling to continue development of Michigan factory serving EV industry
Related articles
- MPs' fury at 'virtue
- Urgent search for P&O cruise ship passenger feared to have fallen overboard near Sydney Harbour
- Kremer pitches 6 shutout innings and Santander hits a grand slam to help Orioles sweep Reds
- Bank holiday scorcher! Temperatures to hit 21C on Monday
- UN Security Council rejects Russia
- Dozens of pro
- Bank holiday scorcher! Temperatures to hit 21C on Monday
- Larson edges Buescher at the line at Kansas Speedway in closest finish in NASCAR Cup Series history
- Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
- Eddie Rosario hits 2
- Australia, New Zealand send planes to evacuate nationals from New Caledonia
- Why Airbus is staying humble even as Boeing flounders
- Heavy rains ease around Houston but flooding remains after hundreds of rescues and evacuations
- Queensland mum stunned by angry neighbour's 'unreasonable' note about crying baby
- Strictly star Nadiya Bychkova reveals she doesn't know if she's on the show's 2024 line
- 1 dead, 6 wounded in Birmingham, Alabama, shooting, police say
- 1 dead in Atlanta area apartment fire that forced residents to jump from balconies
- Shohei Ohtani homers twice as Dodgers sweep Braves with 5
- Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
- Galaxy's McCarthy, Sounders' Frei stellar in scoreless draw
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Stellar Stories news portal sitemap